United States · Health Care · USD (Millions) · Annual
Key financials
USD|Millions
ROE
-9.2%
2025 (actual)
ROA
-4.44%
2025 (actual)
Gross Margin
32.65%
2025 (actual)
Net Margin
-8.09%
2025 (actual)
Total Assets
$11,794.70M
2025 (actual)
Net Income
-$530.20M
2025 (actual)
Valuation
$7,751.07M
2025 (actual)
Stock Price
$11.46
Historical & projected performance
USD|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-67.9 pt
Company
Sector average
ROA
-9.5 pt
Company
Gross Margin
-11.6 pt
Company
Sector average
Net Margin
-15.5 pt
Company
Total Assets
+45.8%
Company
Sector average
Net Income
-339.1%
Company
Valuation
+339.1%
Company
Sector average (own scale)
Stock Price
+339.1%
Company
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Avantor, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.